Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950142-22-001799
Filing Date
2022-06-01
Accepted
2022-06-01 16:01:32
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 eh220257569_424b3-438.htm 424B3 37463
2 GRAPHIC company_logo.jpg GRAPHIC 10406
  Complete submission text file 0000950142-22-001799.txt   47647
Mailing Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801
Business Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

EIN.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-257438 | Film No.: 22987282
SIC: 2834 Pharmaceutical Preparations